EATON: A phase I dose-escalation trial of nazartinib (EGF816) and trametinib in EGFR-mutant non-small cell lung cancer (NSCLC) - preliminary data

Michels, S; Westphal, T; Nogova, L; Scheffler, M; Deschler-Baier, B; Sebastian, M; Schuler, M; Wermke, M; Abdulla, DSY; Fischer, RN; Koleczko, S; Kron, A; Pinto, A; Riedel, R; Weber, JP; Fassunke, J; Merkelbach-Bruse, S; Haverkamp, H; Hellmich, M; Buttner, R; Wolf, J

ONCOLOGY RESEARCH AND TREATMENT, 2020; 43 (SUPPL 4): 148

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索